thelin
pfizer ltd. - sitaxentan natrium - hypertensjon, pulmonal - antihypertensiva, - behandling av pasienter med pulmonal arteriell hypertensjon (pah) klassifisert som who-funksjonsklasse iii, for å forbedre treningskapasiteten. effekt har vist seg ved primær lunghypertensjon og i lungehypertensjon assosiert med bindevevssykdom.
pluvicto
novartis europharm limited - lutetium (177lu) vipivotide tetraxetan - prostatic neoplasmer, kastrering-resistant - terapeutisk radiofarmaka - pluvicto in combination with androgen deprivation therapy (adt) with or without androgen receptor (ar) pathway inhibition is indicated for the treatment of adult patients with progressive prostate-specific membrane antigen (psma)-positive metastatic castration-resistant prostate cancer (mcrpc) who have been treated with ar pathway inhibition and taxane based chemotherapy.
vocabria
viiv healthcare b.v. - cabotegavir sodium, cabotegravir - hiv-infeksjoner - antivirale midler til systemisk bruk - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.
levaxin 50 mikrog
orifarm healthcare a/s - levotyroksinnatrium - tablett - 50 mikrog
levaxin 25 mikrog
orifarm healthcare a/s - levotyroksinnatrium - tablett - 25 mikrog
levaxin 75 mikrog
orifarm healthcare a/s - levotyroksinnatrium - tablett - 75 mikrog
levaxin 100 mikrog
orifarm healthcare a/s - levotyroksinnatrium - tablett - 100 mikrog
levaxin 125 mikrog
orifarm healthcare a/s - levotyroksinnatrium - tablett - 125 mikrog
levaxin 150 mikrog
orifarm healthcare a/s - levotyroksinnatrium - tablett - 150 mikrog
levaxin 175 mikrog
orifarm healthcare a/s - levotyroksinnatrium - tablett - 175 mikrog